Skip to main content
. 2018 Sep 25;109(10):3253–3262. doi: 10.1111/cas.13767

Table 5.

Summary of PK parameters for mAb1024 after a single dose of Sym004 at week 1 and week 4 (weekly regimens) or week 5 (biweekly regimens)

Geometric mean (GCV%)
AUC0‐inf (μg.h/mL) AUC0‐inf/dose (μg.h/mL/mg) C max (μg/mL) t max (h)a t 1/2 (h) CL (L/h) V z (L)
Wk 1
6 mg/kg weekly (n = 3) 5217.9 (26.6) 31.86 (21.9) 54.66 (15.6) 2.05 (2.0, 2.1) 74.08 (8.8) 0.031 (21.9) 3.35 (16.7)
9/6 mg/kg weekly (n = 6) 9182.6 (38.8) 36.20 (37.4) 89.44 (26.2) 7.20 (3.2, 11) 91.30 (21.7) 0.028 (37.4) 3.64 (17.6)
12 mg/kg weekly, Part A (n = 6) 15 075 (34.6) 43.41 (23.1) 116.2 (31.2) 6.66 (3.1,11) 100.1 (24.3) 0.023 (23.1) 3.32 (3.4)
18 mg/kg biweekly (n = 6) 27 554 (30.7) 46.77 (30.9) 187.0 (23.9) 7.15 (3.2, 7.6) 134.5 (27.8) 0.021 (30.9) 4.15 (29.1)
12 mg/kg weekly, Part B (n = 6) 14 781 (17.4) 47.48 (17.5) 146.9b (56.3) 7.13b (3.2, 11) 100.6 (34.8) 0.021 (17.6) 3.06 (47.0)
Wk 4 or 5
6 mg/kg weekly (n = 3) ND ND 89.26 (10.2) 2.07 (2.0, 2.1) ND ND ND
9/6 mg/kg weekly (n = 4) 15 631 (51.4) 94.91 (44.7) 91.70c (33.4) 6.13c (2.0, 18) 117.8 (27.5) 0.017 (30.6) 2.85 (20.6)
12 mg/kg weekly, Part A (n = 6) 41 581 (71.2) 118.1 (57.5) 221.3 (21.1) 5.18 (3.0, 7.3) 155.9 (37.4) 0.016 (32.9) 3.71 (21.7)
18 mg/kg biweekly (n = 5) 43 308 (37.8) 74.28 (36.3) 224.0c (24.7) 5.28c (3.1, 11) 163.6 (36.3) 0.018 (25.6) 4.20 (27.7)
12 mg/kg weekly, Part B (n = 4) 41 351 (42.0) 136.9 (46.8) 231.9c (32.8) 7.10c (3.1, 11) 163.8 (27.5) 0.014 (28.2) 3.40 (24.9)

AUC0‐inf, area under the curve from start of first infusion extrapolated to infinity; C max, maximum concentration; t max, time to C max; t 1/2, half‐life; CL, clearance; V z, apparent volume of distribution during the terminal phase; GCV%, geometric coefficient of variation; ND, not determined.

a

Median and range are reported.

b

n = 7.

c

n = 6.